Arginase inhibitors and methods of use

Details for Australian Patent Application No. 2010206535 (hide)

Owner Arginetix, Inc. The Trustees of the University of Pennsylvania

Inventors Christianson, David W.; Tomczuk, Bruce Edward; Pottorf, Richard Scott; Colasanti, Andrew Vargha; Olson, Gary Lee

Agent Pizzeys

Pub. Number AU-A-2010206535

PCT Pub. Number WO2010/085797

Priority 61/147,270 26.01.09 US

Filing date 26 January 2010

Wipo publication date 29 July 2010

International Classifications

C07C 229/00 (2006.01) Compounds containing amino and carboxyl groups bound to the same carbon skeleton

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/69 (2006.01) - Boron compounds

A61K 49/00 (2006.01) Preparations for testing

Event Publications

28 July 2011 PCT application entered the National Phase

  PCT publication WO2010/085797 Priority application(s): WO2010/085797

24 November 2011 Alteration of Name

  The name of the applicant has been altered to Corridor Pharmaceuticals, Inc.; The Trustees of the University of Pennsylvania

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010206543-Methods for treating acute myocardial infarctions and associated disorders

2010206533-Novel pasteuria strain